HEADER PROTEIN BINDING 01-OCT-19 6L1Y TITLE STRUCTURE OF GP120/CD4 WITH A NON-CANONICAL SURFACE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GP120; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: T-CELL SURFACE GLYCOPROTEIN CD4; COMPND 7 CHAIN: C; COMPND 8 SYNONYM: T-CELL SURFACE ANTIGEN T4/LEU-3; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 EXPRESSION_SYSTEM: INSECT EXPRESSION VECTOR PBLUEBACMSGCA1HIS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 1944738; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 GENE: CD4; SOURCE 11 EXPRESSION_SYSTEM: INSECT EXPRESSION VECTOR PBLUEBACMSGCA1HIS; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 1944738 KEYWDS HIV, GP120, CD4 RECEPTOR, PROTEIN BINDING EXPDTA X-RAY DIFFRACTION AUTHOR X.LIU,W.NING REVDAT 3 22-NOV-23 6L1Y 1 HETSYN REVDAT 2 29-JUL-20 6L1Y 1 COMPND REMARK HETNAM SITE REVDAT 1 20-MAY-20 6L1Y 0 JRNL AUTH L.W.DUAN,H.ZHANG,M.T.ZHAO,J.X.SUN,W.L.CHEN,J.P.LIN,X.Q.LIU JRNL TITL A NON-CANONICAL BINDING INTERFACE IN THE CRYSTAL STRUCTURE JRNL TITL 2 OF HIV-1 GP120 CORE IN COMPLEX WITH CD4. JRNL REF SCI REP V. 7 46733 2017 JRNL REFN ESSN 2045-2322 JRNL PMID 28429756 JRNL DOI 10.1038/SREP46733 REMARK 2 REMARK 2 RESOLUTION. 2.47 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.2_1309 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.47 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.82 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 3 NUMBER OF REFLECTIONS : 21650 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.140 REMARK 3 FREE R VALUE TEST SET COUNT : 1112 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.8150 - 4.9329 1.00 2760 157 0.1813 0.2226 REMARK 3 2 4.9329 - 3.9173 0.98 2652 148 0.1713 0.1997 REMARK 3 3 3.9173 - 3.4227 0.92 2493 137 0.1965 0.2493 REMARK 3 4 3.4227 - 3.1100 0.93 2494 125 0.2202 0.3230 REMARK 3 5 3.1100 - 2.8872 0.94 2517 136 0.2435 0.2980 REMARK 3 6 2.8872 - 2.7170 0.95 2586 124 0.2538 0.3303 REMARK 3 7 2.7170 - 2.5810 0.96 2570 156 0.2624 0.4229 REMARK 3 8 2.5810 - 2.4690 0.92 2466 129 0.2856 0.3602 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.370 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.010 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 49.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.87 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 4233 REMARK 3 ANGLE : 1.342 5725 REMARK 3 CHIRALITY : 0.091 666 REMARK 3 PLANARITY : 0.006 725 REMARK 3 DIHEDRAL : 17.278 1560 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6L1Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 02-OCT-19. REMARK 100 THE DEPOSITION ID IS D_1300014032. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BSRF REMARK 200 BEAMLINE : 3W1A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9792 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21690 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.469 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : 0.03000 REMARK 200 FOR THE DATA SET : 21.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.47 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.47000 REMARK 200 R SYM FOR SHELL (I) : 0.32000 REMARK 200 FOR SHELL : 2.150 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: HKL2MAP REMARK 200 STARTING MODEL: 3TGT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES SODIUM, PH 7.4, 11% PEG REMARK 280 4000 AND 10% 2-PROPANOL, EVAPORATION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.23400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4670 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24490 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 35.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 11 REMARK 465 ASP A 12 REMARK 465 ARG A 13 REMARK 465 ALA A 14 REMARK 465 LYS A 15 REMARK 465 LEU A 16 REMARK 465 LEU A 17 REMARK 465 LEU A 18 REMARK 465 LEU A 19 REMARK 465 LEU A 20 REMARK 465 LEU A 21 REMARK 465 LEU A 22 REMARK 465 LEU A 23 REMARK 465 LEU A 24 REMARK 465 LEU A 25 REMARK 465 PRO A 26 REMARK 465 GLN A 27 REMARK 465 ALA A 28 REMARK 465 GLN A 29 REMARK 465 ALA A 30 REMARK 465 VAL A 31 REMARK 465 GLY A 32 REMARK 465 ASN A 33 REMARK 465 LEU A 34 REMARK 465 TRP A 35 REMARK 465 VAL A 36 REMARK 465 THR A 37 REMARK 465 VAL A 38 REMARK 465 TYR A 39 REMARK 465 TYR A 40 REMARK 465 GLY A 41 REMARK 465 VAL A 42 REMARK 465 PRO A 43 REMARK 465 VAL A 44 REMARK 465 GLY A 404 REMARK 465 THR A 405 REMARK 465 LYS A 406 REMARK 465 SER A 407 REMARK 465 ASN A 408 REMARK 465 LYS A 491 REMARK 465 PRO A 492 REMARK 465 LEU A 493 REMARK 465 GLY A 494 REMARK 465 VAL A 495 REMARK 465 ALA A 496 REMARK 465 PRO A 497 REMARK 465 THR A 498 REMARK 465 THR A 499 REMARK 465 THR A 500 REMARK 465 LYS A 501 REMARK 465 ARG A 502 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 397 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 703 O HOH A 798 2.12 REMARK 500 O HOH A 798 O HOH A 802 2.17 REMARK 500 OE1 GLU A 340 O HOH A 701 2.17 REMARK 500 O PRO A 436 O HOH A 702 2.19 REMARK 500 O4 NAG A 602 O HOH A 703 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 123 -72.43 -126.75 REMARK 500 ASP A 211 110.51 -162.99 REMARK 500 GLN A 258 -60.93 70.66 REMARK 500 ASN A 276 103.38 -178.61 REMARK 500 ASN A 301 66.23 61.94 REMARK 500 PHE A 390 74.21 -119.62 REMARK 500 SER A 410 -137.70 -145.50 REMARK 500 ILE A 438 -173.91 -57.09 REMARK 500 THR A 459 47.07 -72.28 REMARK 500 SER C 19 64.29 -37.30 REMARK 500 LYS C 21 -122.60 -126.10 REMARK 500 LYS C 22 -158.94 -129.36 REMARK 500 GLN C 33 10.83 57.89 REMARK 500 PRO C 48 42.11 -83.66 REMARK 500 VAL C 86 -144.64 -113.45 REMARK 500 ASP C 88 -30.22 74.13 REMARK 500 ASP C 105 -159.86 -67.01 REMARK 500 GLN C 110 -116.05 56.83 REMARK 500 SER C 147 -73.84 -48.50 REMARK 500 LEU C 149 -178.31 -68.00 REMARK 500 GLN C 163 119.49 -164.38 REMARK 500 LYS C 166 118.45 71.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 805 DISTANCE = 6.26 ANGSTROMS REMARK 525 HOH A 806 DISTANCE = 6.74 ANGSTROMS REMARK 525 HOH A 807 DISTANCE = 6.92 ANGSTROMS REMARK 525 HOH A 808 DISTANCE = 7.24 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAG A 601 REMARK 610 NAG A 602 REMARK 610 NAG A 603 REMARK 610 NAG A 604 REMARK 610 NAG A 605 REMARK 610 NAG A 606 REMARK 610 NAG A 607 REMARK 610 NAG A 608 DBREF 6L1Y A 11 502 PDB 6L1Y 6L1Y 11 502 DBREF 6L1Y C 1 177 UNP P01730 CD4_HUMAN 26 202 SEQRES 1 A 392 MET ASP ARG ALA LYS LEU LEU LEU LEU LEU LEU LEU LEU SEQRES 2 A 392 LEU LEU PRO GLN ALA GLN ALA VAL GLY ASN LEU TRP VAL SEQRES 3 A 392 THR VAL TYR TYR GLY VAL PRO VAL TRP LYS GLY ALA THR SEQRES 4 A 392 THR THR LEU PHE CYS ALA SER ASP ALA LYS ALA TYR GLU SEQRES 5 A 392 THR GLU VAL HIS ASN VAL TRP ALA THR HIS ALA CYS VAL SEQRES 6 A 392 PRO ALA ASP PRO ASN PRO GLN GLU MET VAL LEU GLU ASN SEQRES 7 A 392 VAL THR GLU ASN PHE ASN MET TRP LYS ASN ASP MET VAL SEQRES 8 A 392 ASN GLN MET GLN GLU ASP VAL ILE SER LEU TRP ASP GLN SEQRES 9 A 392 SER LEU LYS PRO CYS VAL LYS LEU THR GLY GLY SER ALA SEQRES 10 A 392 ILE THR GLN ALA CYS PRO LYS VAL THR PHE ASP PRO ILE SEQRES 11 A 392 PRO ILE HIS TYR CYS THR PRO ALA GLY TYR ALA ILE LEU SEQRES 12 A 392 LYS CYS ASN ASP LYS ILE PHE ASN GLY THR GLY PRO CYS SEQRES 13 A 392 HIS ASN VAL SER THR VAL GLN CYS THR HIS GLY ILE LYS SEQRES 14 A 392 PRO VAL VAL SER THR GLN LEU LEU LEU ASN GLY SER LEU SEQRES 15 A 392 ALA GLU GLY GLU ILE ILE ILE ARG SER GLU ASN LEU THR SEQRES 16 A 392 ASN ASN VAL LYS THR ILE ILE VAL HIS LEU ASN GLN SER SEQRES 17 A 392 VAL GLU ILE VAL CYS THR ARG PRO GLY ASN GLY GLY ASP SEQRES 18 A 392 ILE ARG GLN ALA HIS CYS ASN ILE SER GLU ASP LYS TRP SEQRES 19 A 392 ASN GLU THR LEU GLN ARG VAL SER LYS LYS LEU ALA GLU SEQRES 20 A 392 HIS PHE GLN ASN LYS THR ILE LYS PHE ALA SER SER SER SEQRES 21 A 392 GLY GLY ASP LEU GLU VAL THR THR HIS SER PHE ASN CYS SEQRES 22 A 392 ARG GLY GLU PHE PHE TYR CYS ASN THR SER GLY LEU PHE SEQRES 23 A 392 ASN GLY ALA TYR THR PRO ASN GLY THR LYS SER ASN SER SEQRES 24 A 392 SER SER ILE ILE THR ILE PRO CYS ARG ILE LYS GLN ILE SEQRES 25 A 392 ILE ASN MET TRP GLN GLU VAL GLY ARG ALA MET TYR ALA SEQRES 26 A 392 PRO PRO ILE LYS GLY ASN ILE THR CYS LYS SER ASN ILE SEQRES 27 A 392 THR GLY LEU LEU LEU VAL ARG ASP GLY GLY THR GLU PRO SEQRES 28 A 392 ASN ASP THR GLU THR PHE ARG PRO GLY GLY GLY ASP MET SEQRES 29 A 392 ARG ASN ASN TRP ARG SER GLU LEU TYR LYS TYR LYS VAL SEQRES 30 A 392 VAL GLU ILE LYS PRO LEU GLY VAL ALA PRO THR THR THR SEQRES 31 A 392 LYS ARG SEQRES 1 C 177 LYS LYS VAL VAL LEU GLY LYS LYS GLY ASP THR VAL GLU SEQRES 2 C 177 LEU THR CYS THR ALA SER GLN LYS LYS SER ILE GLN PHE SEQRES 3 C 177 HIS TRP LYS ASN SER ASN GLN ILE LYS ILE LEU GLY ASN SEQRES 4 C 177 GLN GLY SER PHE LEU THR LYS GLY PRO SER LYS LEU ASN SEQRES 5 C 177 ASP ARG ALA ASP SER ARG ARG SER LEU TRP ASP GLN GLY SEQRES 6 C 177 ASN PHE PRO LEU ILE ILE LYS ASN LEU LYS ILE GLU ASP SEQRES 7 C 177 SER ASP THR TYR ILE CYS GLU VAL GLU ASP GLN LYS GLU SEQRES 8 C 177 GLU VAL GLN LEU LEU VAL PHE GLY LEU THR ALA ASN SER SEQRES 9 C 177 ASP THR HIS LEU LEU GLN GLY GLN SER LEU THR LEU THR SEQRES 10 C 177 LEU GLU SER PRO PRO GLY SER SER PRO SER VAL GLN CYS SEQRES 11 C 177 ARG SER PRO ARG GLY LYS ASN ILE GLN GLY GLY LYS THR SEQRES 12 C 177 LEU SER VAL SER GLN LEU GLU LEU GLN ASP SER GLY THR SEQRES 13 C 177 TRP THR CYS THR VAL LEU GLN ASN GLN LYS LYS VAL GLU SEQRES 14 C 177 PHE LYS ILE ASP ILE VAL VAL LEU HET NAG A 601 14 HET NAG A 602 14 HET NAG A 603 14 HET NAG A 604 14 HET NAG A 605 14 HET NAG A 606 14 HET NAG A 607 14 HET NAG A 608 14 HET EPE A 609 15 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN EPE HEPES FORMUL 3 NAG 8(C8 H15 N O6) FORMUL 11 EPE C8 H18 N2 O4 S FORMUL 12 HOH *123(H2 O) HELIX 1 AA1 GLU A 64 ALA A 73 1 10 HELIX 2 AA2 ASN A 98 LEU A 116 1 19 HELIX 3 AA3 GLU A 335 PHE A 353 1 19 HELIX 4 AA4 ASP A 367 THR A 372 1 6 HELIX 5 AA5 THR A 386 PHE A 390 5 5 HELIX 6 AA6 ASP A 473 TYR A 483 1 11 HELIX 7 AA7 LEU C 51 ASP C 53 5 3 HELIX 8 AA8 ARG C 58 TRP C 62 5 5 HELIX 9 AA9 LYS C 75 SER C 79 5 5 SHEET 1 AA1 5 LYS A 46 GLY A 47 0 SHEET 2 AA1 5 TYR A 485 GLU A 489 -1 O GLU A 489 N LYS A 46 SHEET 3 AA1 5 TYR A 223 CYS A 228 -1 N ALA A 224 O VAL A 488 SHEET 4 AA1 5 VAL A 242 VAL A 245 -1 O SER A 243 N LYS A 227 SHEET 5 AA1 5 GLU A 83 VAL A 85 -1 N MET A 84 O THR A 244 SHEET 1 AA2 3 CYS A 74 PRO A 76 0 SHEET 2 AA2 3 PHE A 53 SER A 56 1 N CYS A 54 O VAL A 75 SHEET 3 AA2 3 HIS A 216 CYS A 218 -1 O HIS A 216 N ALA A 55 SHEET 1 AA3 2 GLU A 91 ASN A 94 0 SHEET 2 AA3 2 THR A 236 CYS A 239 -1 O CYS A 239 N GLU A 91 SHEET 1 AA4 4 ALA A 200 THR A 202 0 SHEET 2 AA4 4 VAL A 120 LEU A 122 -1 N LYS A 121 O ILE A 201 SHEET 3 AA4 4 ARG A 431 MET A 433 -1 O ARG A 431 N LEU A 122 SHEET 4 AA4 4 ILE A 422 ASN A 424 -1 N ILE A 423 O ALA A 432 SHEET 1 AA5 5 LEU A 259 LEU A 261 0 SHEET 2 AA5 5 ILE A 442 ARG A 455 -1 O THR A 449 N LEU A 260 SHEET 3 AA5 5 ILE A 284 ARG A 298 -1 N ILE A 284 O LEU A 453 SHEET 4 AA5 5 THR A 464 PRO A 469 0 SHEET 5 AA5 5 THR A 357 PHE A 360 1 N LYS A 359 O PHE A 467 SHEET 1 AA6 7 ILE A 271 ARG A 273 0 SHEET 2 AA6 7 ILE A 284 ARG A 298 -1 O HIS A 287 N ILE A 271 SHEET 3 AA6 7 ILE A 442 ARG A 455 -1 O LEU A 453 N ILE A 284 SHEET 4 AA6 7 GLN A 328 SER A 334 0 SHEET 5 AA6 7 ILE A 412 LYS A 420 -1 O ILE A 413 N ILE A 333 SHEET 6 AA6 7 GLU A 380 CYS A 384 -1 N TYR A 383 O ARG A 418 SHEET 7 AA6 7 HIS A 373 CYS A 377 -1 N CYS A 377 O GLU A 380 SHEET 1 AA7 6 VAL C 3 LYS C 7 0 SHEET 2 AA7 6 LYS C 90 ALA C 102 1 O GLN C 94 N VAL C 4 SHEET 3 AA7 6 ASP C 80 GLU C 85 -1 N ASP C 80 O LEU C 95 SHEET 4 AA7 6 HIS C 27 LYS C 29 -1 N LYS C 29 O ILE C 83 SHEET 5 AA7 6 LYS C 35 GLN C 40 -1 O ILE C 36 N TRP C 28 SHEET 6 AA7 6 PHE C 43 LYS C 46 -1 O THR C 45 N GLY C 38 SHEET 1 AA8 4 VAL C 3 LYS C 7 0 SHEET 2 AA8 4 LYS C 90 ALA C 102 1 O GLN C 94 N VAL C 4 SHEET 3 AA8 4 THR C 115 GLU C 119 -1 O GLU C 119 N GLY C 99 SHEET 4 AA8 4 THR C 143 SER C 145 -1 O LEU C 144 N LEU C 116 SHEET 1 AA9 3 VAL C 12 LEU C 14 0 SHEET 2 AA9 3 LEU C 69 ILE C 71 -1 O ILE C 71 N VAL C 12 SHEET 3 AA9 3 ALA C 55 ASP C 56 -1 N ASP C 56 O ILE C 70 SHEET 1 AB1 4 ASN C 137 GLY C 140 0 SHEET 2 AB1 4 SER C 127 ARG C 131 -1 N VAL C 128 O GLY C 140 SHEET 3 AB1 4 GLY C 155 LEU C 162 -1 O THR C 158 N ARG C 131 SHEET 4 AB1 4 LYS C 167 ILE C 174 -1 O VAL C 168 N VAL C 161 SSBOND 1 CYS A 54 CYS A 74 1555 1555 2.05 SSBOND 2 CYS A 119 CYS A 205 1555 1555 2.04 SSBOND 3 CYS A 218 CYS A 247 1555 1555 2.03 SSBOND 4 CYS A 228 CYS A 239 1555 1555 2.03 SSBOND 5 CYS A 296 CYS A 331 1555 1555 2.04 SSBOND 6 CYS A 377 CYS A 444 1555 1555 2.02 SSBOND 7 CYS A 384 CYS A 417 1555 1555 2.04 SSBOND 8 CYS C 16 CYS C 84 1555 1555 2.02 SSBOND 9 CYS C 130 CYS C 159 1555 1555 2.05 CISPEP 1 ASN A 301 GLY A 323 0 -0.44 CISPEP 2 GLN C 165 LYS C 166 0 -15.80 CRYST1 68.444 66.468 73.850 90.00 108.40 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014610 0.000000 0.004860 0.00000 SCALE2 0.000000 0.015045 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014271 0.00000